hemotune is featured by Forbes
hemotune AG is featured as Nr. 1 Spin-off to watch by Forbes DACH in their current edition.
Read the full coverstory in Forbes DACH about hemotune AG, as well as about our founders - CEO Lukas Langenegger and CSO Carlos Andrea Mora.
You will learn more about our background as ETH Zürich spinoff at Wyss Zurich, why sepsis is one of the largest global health challenges and how we plan to use our unique multitarget blood purification platform to improve treatment options for this deadly disease.
Click below to read the English version of the article: